Preparation of electrospun poly(l-lactide-co-caprolactone-co-glycolide)/phospholipid polymer/rapamycin blended fibers for vascular application

Hyung Il Kim, Ryosuke Matsuno, Ji-Hun Seo, Tomohiro Konno, Madoka Takai, Kazuhiko Ishihara

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Nanopores generated from the gap among electrospun nanofibers can provide vascular tissues with oxygen, nutrients, and growth factors. Here, we report the first fabrication of poly(l-lactide-co-caprolactone-co-glycolide) (PLCG) electrospun nanofibers. A water-soluble amphiphilic copolymer bearing phosphorylcholine groups (PMB30W) and an antiproliferative (rapamycin) were incorporated into PLCG by solvent blending and subsequent electrospinning. The nanostructure of the electrospun PLCG/PMB30W/rapamycin blended fibers was stable during incubation in phosphate-buffered saline without addition of chemical crosslinkers. Amphiphilic characteristics of PMB30W and hydrophobic nature of rapamycin could make the electrospun PLCG/PMB30W/rapamycin blended fibers stable under a physiologic condition. The electrospun PLCG/PMB30W/rapamycin blended fibers may be preferable for vascular prostheses and tissue-engineered vascular grafts.

Original languageEnglish
JournalCurrent Applied Physics
Volume9
Issue number4 SUPPL.
DOIs
Publication statusPublished - 2009 Jul 1
Externally publishedYes

Fingerprint

Phospholipids
Sirolimus
Polymers
Nanofibers
preparation
fibers
Fibers
polymers
Bearings (structural)
Tissue
Nanopores
nutrients
Electrospinning
Prosthetics
Grafts
Nutrients
Nanostructures
copolymers
phosphates
Phosphates

Keywords

  • Artificial vessels
  • Electrospinning
  • Phospholipid polymer
  • poly(l-lactide-co-caprolactone-co-glycolide)
  • Rapamycin

ASJC Scopus subject areas

  • Materials Science(all)
  • Physics and Astronomy(all)

Cite this

Preparation of electrospun poly(l-lactide-co-caprolactone-co-glycolide)/phospholipid polymer/rapamycin blended fibers for vascular application. / Kim, Hyung Il; Matsuno, Ryosuke; Seo, Ji-Hun; Konno, Tomohiro; Takai, Madoka; Ishihara, Kazuhiko.

In: Current Applied Physics, Vol. 9, No. 4 SUPPL., 01.07.2009.

Research output: Contribution to journalArticle

Kim, Hyung Il ; Matsuno, Ryosuke ; Seo, Ji-Hun ; Konno, Tomohiro ; Takai, Madoka ; Ishihara, Kazuhiko. / Preparation of electrospun poly(l-lactide-co-caprolactone-co-glycolide)/phospholipid polymer/rapamycin blended fibers for vascular application. In: Current Applied Physics. 2009 ; Vol. 9, No. 4 SUPPL.
@article{e81ef78d87cc4897bed0532a79fee5a7,
title = "Preparation of electrospun poly(l-lactide-co-caprolactone-co-glycolide)/phospholipid polymer/rapamycin blended fibers for vascular application",
abstract = "Nanopores generated from the gap among electrospun nanofibers can provide vascular tissues with oxygen, nutrients, and growth factors. Here, we report the first fabrication of poly(l-lactide-co-caprolactone-co-glycolide) (PLCG) electrospun nanofibers. A water-soluble amphiphilic copolymer bearing phosphorylcholine groups (PMB30W) and an antiproliferative (rapamycin) were incorporated into PLCG by solvent blending and subsequent electrospinning. The nanostructure of the electrospun PLCG/PMB30W/rapamycin blended fibers was stable during incubation in phosphate-buffered saline without addition of chemical crosslinkers. Amphiphilic characteristics of PMB30W and hydrophobic nature of rapamycin could make the electrospun PLCG/PMB30W/rapamycin blended fibers stable under a physiologic condition. The electrospun PLCG/PMB30W/rapamycin blended fibers may be preferable for vascular prostheses and tissue-engineered vascular grafts.",
keywords = "Artificial vessels, Electrospinning, Phospholipid polymer, poly(l-lactide-co-caprolactone-co-glycolide), Rapamycin",
author = "Kim, {Hyung Il} and Ryosuke Matsuno and Ji-Hun Seo and Tomohiro Konno and Madoka Takai and Kazuhiko Ishihara",
year = "2009",
month = "7",
day = "1",
doi = "10.1016/j.cap.2009.06.001",
language = "English",
volume = "9",
journal = "Current Applied Physics",
issn = "1567-1739",
publisher = "Elsevier",
number = "4 SUPPL.",

}

TY - JOUR

T1 - Preparation of electrospun poly(l-lactide-co-caprolactone-co-glycolide)/phospholipid polymer/rapamycin blended fibers for vascular application

AU - Kim, Hyung Il

AU - Matsuno, Ryosuke

AU - Seo, Ji-Hun

AU - Konno, Tomohiro

AU - Takai, Madoka

AU - Ishihara, Kazuhiko

PY - 2009/7/1

Y1 - 2009/7/1

N2 - Nanopores generated from the gap among electrospun nanofibers can provide vascular tissues with oxygen, nutrients, and growth factors. Here, we report the first fabrication of poly(l-lactide-co-caprolactone-co-glycolide) (PLCG) electrospun nanofibers. A water-soluble amphiphilic copolymer bearing phosphorylcholine groups (PMB30W) and an antiproliferative (rapamycin) were incorporated into PLCG by solvent blending and subsequent electrospinning. The nanostructure of the electrospun PLCG/PMB30W/rapamycin blended fibers was stable during incubation in phosphate-buffered saline without addition of chemical crosslinkers. Amphiphilic characteristics of PMB30W and hydrophobic nature of rapamycin could make the electrospun PLCG/PMB30W/rapamycin blended fibers stable under a physiologic condition. The electrospun PLCG/PMB30W/rapamycin blended fibers may be preferable for vascular prostheses and tissue-engineered vascular grafts.

AB - Nanopores generated from the gap among electrospun nanofibers can provide vascular tissues with oxygen, nutrients, and growth factors. Here, we report the first fabrication of poly(l-lactide-co-caprolactone-co-glycolide) (PLCG) electrospun nanofibers. A water-soluble amphiphilic copolymer bearing phosphorylcholine groups (PMB30W) and an antiproliferative (rapamycin) were incorporated into PLCG by solvent blending and subsequent electrospinning. The nanostructure of the electrospun PLCG/PMB30W/rapamycin blended fibers was stable during incubation in phosphate-buffered saline without addition of chemical crosslinkers. Amphiphilic characteristics of PMB30W and hydrophobic nature of rapamycin could make the electrospun PLCG/PMB30W/rapamycin blended fibers stable under a physiologic condition. The electrospun PLCG/PMB30W/rapamycin blended fibers may be preferable for vascular prostheses and tissue-engineered vascular grafts.

KW - Artificial vessels

KW - Electrospinning

KW - Phospholipid polymer

KW - poly(l-lactide-co-caprolactone-co-glycolide)

KW - Rapamycin

UR - http://www.scopus.com/inward/record.url?scp=71849087382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71849087382&partnerID=8YFLogxK

U2 - 10.1016/j.cap.2009.06.001

DO - 10.1016/j.cap.2009.06.001

M3 - Article

VL - 9

JO - Current Applied Physics

JF - Current Applied Physics

SN - 1567-1739

IS - 4 SUPPL.

ER -